Genetics, Vol. 150, 577-589, October 1998, Copyright © 1998

An arf1{Delta} Synthetic Lethal Screen Identifies a New Clathrin Heavy Chain Conditional Allele That Perturbs Vacuolar Protein Transport in Saccharomyces cerevisiae

Chih-Ying Chena and Todd R. Grahama
a Department of Molecular Biology, Vanderbilt University, Nashville, Tennessee 37235

Corresponding author: Todd R. Graham, Department of Molecular Biology, Box 1820 Station B, Vanderbilt University, Nashville, TN 37235., grahamtr{at}ctrvax.vanderbilt.edu (E-mail).

Communicating editor: E. W. JONES


*  ABSTRACT
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

ADP-ribosylation factor (ARF) is a small GTP-binding protein that is thought to regulate the assembly of coat proteins on transport vesicles. To identify factors that functionally interact with ARF, we have performed a genetic screen in Saccharomyces cerevisiae for mutations that exhibit synthetic lethality with an arf1{Delta} allele and defined seven genes by complementation tests (SWA1-7 for synthetically lethal with arf1{Delta}). Most of the swa mutants exhibit phenotypes comparable to arf1{Delta} mutants such as temperature-conditional growth, hypersensitivity to fluoride ions, and partial protein transport and glycosylation defects. Here, we report that swa5-1 is a new temperature-sensitive allele of the clathrin heavy chain gene (chc1-5), which carries a frameshift mutation near the 3' end of the CHC1 open reading frame. This genetic interaction between arf1 and chc1 provides in vivo evidence for a role for ARF in clathrin coat assembly. Surprisingly, strains harboring chc1-5 exhibited a significant defect in transport of carboxypeptidase Y or carboxypeptidase S to the vacuole that was not observed in other chc1 ts mutants. The kinetics of invertase secretion or transport of alkaline phosphatase to the vacuole were not significantly affected in the chc1-5 mutant, further implicating clathrin specifically in the Golgi to vacuole transport pathway for carboxypeptidase Y.


PROTEIN transport between distinct organelles in eukaryotic cells is carried out by membrane-bound vesicles. Formation of transport vesicles involves assembly of cytosolic coat proteins onto the donor membrane, selective packaging of the cargo proteins and finally budding of the coated vesicles. Several types of vesicle coats that mediate different protein transport steps have been studied in detail (reviewed in SCHEKMAN and ORCI 1996 Down). The Sec23/24p and Sec13/31p complexes form COPII, which coats vesicles that bud from the endoplasmic reticulum (ER). Coatomer, a heptameric ({alpha},ß,ß',{gamma},{delta},{epsilon},{zeta}-COP) protein complex, coats COPI vesicles that mediate transport from the Golgi to the ER and between Golgi compartments. Two types of coat proteins contain clathrin, which is composed of heavy chains and light chains, associated with different adaptor protein (AP) complexes. In mammalian cells, clathrin/AP-1 coated vesicles bud from the trans-Golgi network and deliver cargo to endosomal compartments, while clathrin/AP-2 drives endocytosis from the plasma membrane. Recently, a third adaptor complex (AP-3) has been identified (SIMPSON et al. 1996 Down), which in yeast appears to mediate the delivery of proteins from the trans-Golgi network directly to the vacuole (COWLES et al. 1997 Down; PIPER et al. 1997 Down; STEPP et al. 1997 Down). This AP-3 complex has been suggested to function independently of clathrin (SIMPSON et al. 1996 Down; PANEK et al. 1997 Down) although a recent study reported a direct interaction between AP-3 and the clathrin heavy chain in vitro (DELL'ANGELICA et al. 1998 Down).

Small GTP-binding proteins are required to initiate (or prime) assembly of the coats. As Sar1p functions to recruit COPII to the ER membrane, ADP-ribosylation factor (ARF) appears to be required on the Golgi membrane to recruit COPI or AP-1/clathrin coats (SCHEKMAN and ORCI 1996 Down). The involvement of ARF in clathrin/AP-1 recruitment was first suggested by the observation that AP-1 dissociated from Golgi membranes of cells treated with brefeldin A (ROBINSON and KREIS 1992 Down; WONG and BRODSKY 1992 Down), a drug that is thought to specifically inhibit an ARF guanine nucleotide exchange factor (DONALDSON et al. 1992 Down; HELMS and ROTHMAN 1992 Down; MORINAGA et al. 1996 Down; PEYROCHE et al. 1996 Down). In vitro, the binding of AP-1 to Golgi membranes and subsequent recruitment of clathrin is dependent upon the GTP{gamma}S-activated form of ARF (STAMNES and ROTHMAN 1993 Down; TRAUB et al. 1993 Down). However, GTP{gamma}S-activated ARF can also mediate recruitment of AP-2 and COPI to endosomal membranes (SEAMAN et al. 1993 Down; WHITNEY et al. 1995 Down), and COPI to ER membranes (BEDNAREK et al. 1995 Down) and can inhibit endosome-endosome fusion (LENHARD et al. 1992 Down) and nuclear envelope reassembly (BOMAN et al. 1992 Down). The in vivo significance of these observations is still not clear. In addition, treatment of cells with brefeldin A causes the dissociation of many proteins peripherally associated with the Golgi (KOOY et al. 1992 Down; PODOS et al. 1994 Down; MISUMI et al. 1997 Down) and it is not known if this represents a direct requirement for ARF in Golgi binding or is an indirect consequence of perturbing Golgi structure and function.

In yeast Saccharomyces cerevisiae, ARF is encoded by two genes, ARF1 and ARF2, which encode proteins with 96% identity that are probably redundant in function (STEARNS et al. 1990A Down). Double arf1{Delta} arf2{Delta} mutants are inviable, indicating that ARF is an essential protein in yeast. The Arf2 protein is only expressed at 10% of the level of Arf1 protein, and strains carrying a deletion of the ARF2 gene show a wild-type phenotype (STEARNS et al. 1990A Down, STEARNS et al. 1990B Down). Strains harboring a deletion of ARF1 grow well, yet exhibit modest defects in protein secretion and modification (STEARNS et al. 1990A Down), and, perhaps more significantly, arf1{Delta} mutants exhibit a substantial alteration in the structure of Golgi and endosomal compartments (GAYNOR et al. 1998 Down). This suggests that ARF plays a role not only in protein transport but also in organelle membrane dynamics (GAYNOR et al. 1998 Down). Strains harboring the arf1{Delta} null mutation combined with mutations in RET1, SEC21, and SEC27, which respectively encode {alpha}-, {gamma}-, and ß'-COP subunits of the coatomer complex, were found to display a synthetic growth defect, whereas double mutants harboring arf1{Delta} combined with several other sec mutations do not exhibit synthetic growth defects (STEARNS et al. 1990B Down; GAYNOR et al. 1998 Down). This provides in vivo evidence that ARF plays a specific role in coatomer function; however, there is no such genetic evidence yet for ARF in the assembly of AP-1/clathrin coats.

To identify other proteins that functionally interact with Arf1p, we have employed a genetic screen to search for the mutations that display synthetic lethality in combination with the arf1{Delta} null mutation and have identified seven complementation groups (SWA1-7 for synthetically lethal with arf1{Delta}). In this study, we focused on characterization of SWA5, which was found to be allelic to the clathrin heavy chain gene (CHC1). This genetic interaction between arf1{Delta} and chc1 provides in vivo support for a role for ARF in clathrin coat assembly. Surprisingly, chc1-5 (swa5-1) mutants exhibited markedly slow transport kinetics for carboxypeptidase Y (CPY) that was not observed in three other chc1 temperature-sensitive (ts) mutants. The effect of chc1-5 on CPY transport was much more substantial than the effect on invertase or alkaline phosphatase transport, further implicating clathrin in transport of CPY from the Golgi to the vacuole.


*  MATERIALS AND METHODS
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

Media, strains, and plasmid construction:
Yeast strains and plasmids used in this study are listed in Table 1. CCY2011C and CCY2804C are meiotic progeny from crosses of CH1305 (KRANZ and HOLM 1990 Down) with 6210 arf1{Delta} and of CH1304 (KRANZ and HOLM 1990 Down) with 6211 arf1{Delta} (GAYNOR et al. 1998 Down), respectively. The swa5-1 mutant (CCY2017) was backcrossed three times with a wild-type yeast strain (SEY6210) to produce CCY620-5. Yeast cells were grown on yeast extract, peptone, and dextrose (YPD), synthetic minimal (SD) media supplemented as necessary (SHERMAN 1991 Down). FOA (5'-fluoroorotic acid; Sigma, St. Louis) media counterselective against growth of Ura+ cells were prepared as described (SIKORSKI and BOEKE 1991 Down). Cells were grown overnight in liquid SD media containing 0.2% yeast extract and required supplements for metabolic labeling experiments.


 
View this table:
In this window
In a new window

 
Table 1. Yeast strains and plasmids used

Plasmids pCC8218 and pCC616 were generated as follows: a 1.8-kb EcoRI-PstI fragment carrying ARF1 was subcloned from pRB1297 (STEARNS et al. 1990A Down) into the polylinker of pPolyIII (LATHE et al. 1987 Down) to produce pPolyIII-ARF1. An ~1.8-kb NotI fragment from pPolyIII-ARF1 was inserted into pCH1153 (KRANZ and HOLM 1990 Down) to produce pCC8218 and an ~1.8-kb PstI-BamHI fragment from pPolyIII-ARF1 was subcloned into pRS315 (SIKORSKI and HIETER 1989 Down) to produce pCC616. To produce pCC416, a 7.7-kb SalI-NruI fragment carrying CHC1 was subcloned from pCC1-2 (isolated from a genomic library) into the SalI-SmaI sites of pRS416 (SIKORSKI and HIETER 1989 Down).

The isogenic chc1-ts strains were prepared by targeted integration of 5' truncated chc1 alleles into the CHC1 locus (depicted in Figure 7B). YIpchc521{Delta}Cla (TAN et al. 1993 Down) was used to prepare the 6210 chc1-521 strain. To prepare pCC306 chc1-5, a 7.4-kb SalI-NotI fragment carrying chc1-5 was subcloned from pCC416-1 into pRS306 (SIKORSKI and HIETER 1989 Down). A 7.6-kb AatII-SalI fragment carrying chc1-{Delta}57 was subcloned from p{Delta}57 (LEMMON et al. 1991 Down) into the SmaI-SalI sites of pRS306 to produce pCC306 chc1-{Delta}57. The 5' ends of the chc1 genes were deleted by digesting the pCC306 plasmids with BglII and ClaI, blunt-ending and ligating to generate the 3' chc1 series of plasmids. To prepare p 3'chc1-{Delta}43, two PCR primers were designed to delete the C-terminal 43 amino acids of Chc1p: one is upstream of the last BamHI site in the CHC1 open reading frame (5'-ACAAATTTGACCAATTGGGATTG-3'); the other introduces two stop codons and a SalI site after codon 1610 (5'-CGTCGAGTCGACTCATTATTTTTTTATGGAGATTTCAAATGGC-3'). After PCR amplification, the products were digested with SalI and BamHI and subcloned into the SalI-BamHI sites of p 3'chc1-5. To generate the 6210 chc1 mutants, the p 3'chc1 plasmids were linearized with AftII and transformed into SEY6210 to target integration into the chromosomal CHC1 locus. Ura+ transformants were tested for ts growth. Total DNA was then isolated from ts transformants and the correct integration event was confirmed by PCR and DNA sequencing.




View larger version (140K):
In this window
In a new window
Download PPT slide
 
Figure 1. Synthetic defects exhibited by arf1{Delta} swa5-1 double mutants. (A) Wild type (CCY2011, arf1{Delta} SWA5 pARF1) and the swa5-1 mutant (CCY2017, arf1{Delta} swa5-1 pARF1) on YPD medium at 30° form red/white sectoring and uniformly red colonies, respectively. The nonsectoring phenotype of the mutant indicates that arf1{Delta} swa5-1 double mutants can survive only when the plasmid (pCC8218) carrying ARF1-ADE3 is present. (B) Tetrad analysis of progeny derived from a cross between wild-type and swa5-1 strains. The swa5-1 mutant (CCY2017) was mated with the parental wild-type strain (CCY2011). The resultant diploids were sporulated, and meiotic segregants were incubated on YPD medium at 30°. Because the ARF1-ADE3-URA3 plasmid (pCC8218) was lost frequently during meiosis, each tetrad yielded two robust (arf1{Delta} SWA5) and two extremely slow-growing or inviable (arf1{Delta} swa5-1) spore clones, indicating that the arf1{Delta} synthetic growth is caused by a single gene mutation, swa5-1.



View larger version (41K):
In this window
In a new window
Download PPT slide
 
Figure 2. Characterization of the swa mutants. (A) Seven complementation groups were defined by complementation tests and tetrad analyses. Strains tested were wild-type, CCY 2011 or CCY2804 (arf1{Delta} SWA pARF1); arf1{Delta}, CCY2011C or CCY2804C (arf1{Delta} SWA); and swa mutants (arf1{Delta} swa pARF1) isolated from mutagenized cultures of the wild-type strains. Numbers of alleles displaying cs or ts phenotype are indicated in parentheses. Fluoride sensitivity was tested on freshly prepared YPD media containing 0, 20, 40, 60, or 80 mM NaF. Strains tested for F- sensitivity were CCY2013 (swa1-2), CCY2807 (swa2-2), CCY2808 (swa3-2), CCY2016 (swa4-1), CCY2017 (swa5-1), CCY2018 (swa7-1), CCY2011C and CCY2804C (arf1{Delta}), and CCY2011 and CCY2804 (wild type). The numbers shown are the lowest concentrations of NaF on which the mutants failed to grow. CPY transport was scored based on pulse-chase experiments as shown in B and C: ++++ indicates transport as efficient as wild type, +++ is slightly (one- to twofold) slower than wild type, ++ is as slow as the arf1{Delta} mutants (two- to threefold slower than wild type), and + is more than threefold slower transport than wild type. (B and C) Pulse-chase analysis of CPY transport in the swa mutants. Strains tested were CCY2013 (swa1-2), CCY2807 (swa2-2), CCY2808 (swa3-2), CCY2811 (swa4-2), CCY2017 (swa5-1), CCY2018 (swa7-1), CCY2804C (arf1{Delta}), and CCY2804 (WT). Cells were grown at 30° to mid-log phase. After shifting to a nonpermissive temperature (15° for cs, B; 37° for ts, C) for 1 hr, cells were labeled for 10 min and then chased for the indicated times and processed for immunoprecipitation with antiserum to CPY.





View larger version (149K):
In this window
In a new window
Download PPT slide
 
Figure 3. CHC1 complements both ts growth and protein transport defects of the swa5-1 mutant. (A) Single copy plasmids containing CDC68 and CHC1 (pCC1-2) or CHC1 alone (pCC315 CHC1) were able to complement the ts growth defect of a swa5-1 mutant (CCY620-5, ARF1 swa5-1). Deletion of NsiI fragments in pCC1-2 disrupted the ability to complement the ts phenotype. (B) Growth of CCY620-5 (swa5-1) pCC315 CHC1 and CCY620-5 (swa5-1) pRS315 on SD minus leucine medium incubated at the indicated temperatures. (C) SEY6210 (SWA5), CCY620-5 (swa5-1), CCY620-5 pCC315-CHC1 (swa5-1 pCHC1), and CCY620-5 pRS315 (swa5-1 vector only) were grown at 30° to mid-log phase and converted to spheroplasts. After they were shifted to 37° for 1 hr, cells were labeled for 10 min and then chased for 0, 15, and 30 min. Cells and medium were separated by centrifugation and processed for immunoprecipitation with antiserum to CPY.



View larger version (14K):
In this window
In a new window
Download PPT slide
 
Figure 4. The swa5-1 mutation maps near the 3' end of CHC1. Plasmids with the CHC1 open reading frame (pCC416) gapped at four different regions with the indicated restriction enzymes were transformed into CCY620-5 (swa5-1). Repaired plasmids were recovered from the yeast transformants and then amplified in Escherichia coli and retransformed back into CCY620-5. A plasmid (pCC416-1) gap-repaired at the very 3' end of CHC1 (gap 1) failed to complement the swa5-1 ts growth defect whereas those originally gapped elsewhere complemented. The dashed line indicates DNA copied from the CHC1 locus of the swa5-1 mutant.



View larger version (42K):
In this window
In a new window
Download PPT slide
 
Figure 5. Stability of Chc1p at 37° in chc1 and wild-type CHC1 cells. Strains SEY6210 (CHC1, lanes 1–3), CCY620-5 (chc1-5, lanes 4–6), GPY55-10B (CHC1, lanes 7–9), GPY396.1 (chc1-521, lanes 9–12), and GPY1103 (chc1-{Delta}, lane 13) were grown at 23° and shifted to 37° for 0, 1, or 2 hr before lysis. Total cellular proteins were subjected to SDS-PAGE and immunoblotted with monoclonal antibody against clathrin heavy chain (top) or CPY (bottom).



View larger version (13K):
In this window
In a new window
Download PPT slide
 
Figure 6. Mislocalization of an Mnn1-invertase fusion protein to the plasma membrane of the chc1-5 mutant. Strains SEY6210 (WT) and CCY620-5 (chc1-5) harboring pM39S were grown at 23° to 0.5–1.0 OD600/ml. The cultures were shifted to 37° and aliquots were removed at the indicated time points. The percentage of invertase at the cell surface was determined as previously described (GRAHAM and KRASNOV 1995 Down).




View larger version (35K):
In this window
In a new window
Download PPT slide
 
Figure 7. CPY transport in isogenic chc1 ts mutants. (A) Schematic representation of the C termini of clathrin heavy chain encoded by the indicated chc1 alleles. The trimerization domain is indicated by the solid bar and underline and encompasses residues 1550–1615 in bovine Chc, which approximately correspond to residues 1556–1621 in yeast Chc1p. (B) Schematic representation depicting the construction of isogenic chc1 mutants. As described in detail in MATERIALS AND METHODS, p 3'chc1 plasmids were linearized with AftII and transformed into SEY6210 to target integration into the CHC1 locus on chromosome VII. Wild-type CHC1 and the 3' end half of mutant chc1 were indicated by solid and gray arrows, respectively. The asterisk (*) indicates the region where the chc1 ts mutation resides. (C) CHC1, chc1-5, chc-{Delta}43, chc1-{Delta}57, and chc1-521 (isogenic strains in SEY6210 genetic background) were grown at 23° to mid-log phase. After shifting to 37° for 1 hr, cells were labeled for 10 min, then chased for 0, 15, 30, and 60 min, and processed for immunoprecipitation with antiserum to CPY.

Isolation and characterization of swa mutants:
To start the screen, CCY2011 and CCY2804 were grown at 30° in liquid SD medium lacking uracil to stationary phase and treated with 3% ethyl methanesulfonate (Fluka, St. Louis) for 30 min at 30° (LAWRENCE 1991 Down), which resulted in ~60–80% survival. Cells were plated on YPD to yield ~500 colonies per plate and incubated at 30° for 5–6 days. Uniformly red colonies were streaked twice onto YPD plates to confirm the nonsectoring phenotype and finally onto FOA medium to confirm plasmid-dependent growth. Mutant strains were crossed with the parental strain of opposite mating type and an ARF1 ARF2 ade2 ade3 strain, and the resulting diploids were replica-plated onto FOA medium to determine if mutations were recessive and if the nonsectoring phenotype resulted from plasmid integration, respectively. All of the diploids were FOAR indicating that the mutations were recessive and that none of the mutants recombined the URA3 and ADE3 genes into a chromosome. For complementation analysis, mutants of opposite mating type were intercrossed and the resulting diploids were replica-plated onto FOA medium. To distinguish mutants that required ARF1 for survival from those that required ADE3 or URA3, mutants were transformed with pCC616 and the transformants were tested for growth on FOA and YPD media. FOAR or sectoring transformants were taken as ARF1-dependent. The results of the mutant screen are summarized as follows: 63 nonsectoring mutants were isolated, among which 3 were ARF1-independent, 16 were assigned to SWA1- SWA7, 12 contained multiple mutations and were discarded, and 32 were set aside that could not clearly be assigned to a complementation group and did not exhibit a temperature conditional growth defect.

To test for complementation or suppression of swa mutants by known genes, pEP1 (2µ GCS1 LEU2 AmpR, a gift from G. C. Johnston, Dalhousie University, Canada), pCLJ80 (2µ GEA1 LEU2 AmpR; PEYROCHE et al. 1996 Down), and AFB550 (CEN SEC7 LEU2 AmpR, a gift from A. Franzusoff, University of Colorado Health Sciences Center) were transformed into a representative mutant from each complementation group and streaked on YPD plates to score the sectoring phenotype. In addition, all of the swa ts mutants were crossed with strains EGY1211-8c or EGY1211-14d (sec21-1, provided by S. Emr, University of California, San Diego) and the resultant strains were tested for growth at 37°. Unassigned mutants have not yet been tested.

To clone SWA5, a genomic library (HORAZDOVSKY et al. 1994 Down) was transformed into CCY620-5, and Leu+ transformants were replica-plated onto selective medium and incubated at 37°. Plasmid pCC1-2 isolated from a colony that grew at 37° was retransformed into CCY620-5 to confirm the ability to rescue the ts phenotype and was partially sequenced.

Cell labeling, immunoblotting, and invertase assay:
Pulse-chase metabolic labeling of cells with 35S amino acids and immunoprecipitations was done as previously described (GAYNOR et al. 1994 Down). To examine the secretion of invertase to the periplasmic space, CCY620-5 pCYI-20-308 transformants were converted to spheroplasts after pulse-chase labeling as previously described (GAYNOR and EMR 1997 Down). Half-times of transport were determined as previously described (GAYNOR et al. 1998 Down). For immunoblot analysis, yeast cultures were grown overnight at 23° in YPD to mid-log phase. Ten OD600 of cells were collected, resuspended in 100 µl SDS-urea buffer (1% SDS; 6 M urea; 50 mM Tris-Cl, pH 7.5; and 1 mM EDTA), and lysed by vortexing with glass beads. Lysates containing 2 OD600 equivalents were mixed with 4x Laemmli sample buffer and subjected to SDS-PAGE. Western blots were probed with mouse monoclonal antibodies against CPY (Molecular Probes, Eugene, OR) and Chc1p (LEMMON et al. 1988 Down), followed by incubation with horseradish peroxidase-conjugated goat anti-mouse antiserum (Jackson ImmunoResearch, West Grove, PA) and detection using Enhanced Chemiluminescence (Amersham, Arlington Heights, IN). Invertase assays were performed as previously described (GRAHAM and KRASNOV 1995 Down).


*  RESULTS
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

Isolation of mutants that require Arf1p for survival:
To better understand the primary function of ARF in vivo, we performed a genetic screen to search for the genes that, when mutated in an arf1{Delta} null background, lead to a lethal phenotype. An ade2 ade3 based colony-sectoring assay (KOSHLAND et al. 1985 Down; KRANZ and HOLM 1990 Down; BENDER and PRINGLE 1991 Down) was used to easily identify mutants that are able to live only when wild-type ARF1 is present. Strains that harbor arf1{Delta} ade2 ade3 mutations (CCY2804C and CCY2011C) are white, while the transformants carrying wild-type ARF1 and ADE3 genes linked together on a plasmid (pCC8218, URA3-based) form red colonies that contain white sectors (Figure 1A). This sectoring phenotype indicates the cells can readily lose the ARF1-ADE3-URA3 plasmid, which is also demonstrated by the ability of these strains to grow on medium containing FOA, a drug that selects against cells harboring the URA3 gene. Among ~19,000 colonies that survived ethyl methanesulfonate treatment, 63 mutant colonies consistently showed a nonsectoring red phenotype on YPD medium (Figure 1A) and no growth on FOA at 30°, indicating that these strains could not survive without the plasmid. Three mutants were discarded because they were unable to lose the original ARF1-ADE3-URA3 plasmid when transformed with ARF1 carried on a LEU2-based vector (pCC616), suggesting the mutations that caused the nonsectoring phenotype were independent of Arf1p.

Because protein secretion is an essential process, mutations in genes involved in the secretory pathway usually affect the growth of the mutants. We screened for mutants that grew well at 30°. However, it was possible that these mutants would exhibit a conditional growth defect. Because the nonsectoring mutants harbor a copy of wild-type ARF1 on a plasmid, additional phenotypes, such as temperature conditional growth, should be attributable to the swa mutations. Therefore, all 60 of the mutants were examined for cold sensitive (cs) or temperature sensitive (ts) defects in growth at 15° or 37°, respectively. Thirty-five of the mutants were either cs, ts, or both.

From backcrosses to parental strains it was determined that all the mutants contained recessive mutations (see MATERIALS AND METHODS). Four complementation groups each containing two or more alleles were defined (SWA1-SWA4, Figure 2A) by intercrossing the mutants and testing for complementation of the nonsectoring phenotype in diploids. From this analysis, 47 mutants remained unassigned, including 27 that exhibited a conditional growth defect.

All of the strains displaying a conditional growth phenotype were analyzed directly for protein transport defects by pulse-chase experiments at their nonpermissive temperature and immunoprecipitation of the vacuolar protein CPY (described in detail below). Ten of the 27 unassigned conditional mutants displayed a defect in CPY transport or glycosylation and were characterized further to determine if this phenotype was caused by a single gene mutation. The mutants were backcrossed with the parental strain, diploids were sporulated, and tetrads were dissected. During the tetrad analyses, we found that the ARF1-ADE3-URA3 plasmid was frequently lost during meiosis and not recovered in the progeny. For example, instead of finding two sectoring vs. two nonsectoring progeny from a heterozygous diploid carrying a single gene mutation, two viable (white, arf1{Delta} SWA) vs. two dead (arf1{Delta} swa) progeny were usually observed (Figure 1B). Three more complementation groups were confirmed by the tetrad analyses, each containing one mutant allele, and designated as SWA5-SWA7. Seven of the temperature conditional mutants did not show 2:2 segregation of the synthetic lethal phenotype, indicative of multiple mutations, and thus were not characterized further (see MATERIALS AND METHODS). For swa5-1, ~50% of the predicted double mutant progeny were not able to survive without the plasmid carrying ARF1 (Figure 1B). The surviving swa5-1 arf1{Delta} double mutants grew extremely poorly relative to swa5-1 or arf1{Delta} single mutants, which indicated that the genetic interaction between swa5-1 and arf1{Delta} ranged from a strong synthetic growth defect to lethality.

The pulse-chase analyses were repeated to examine the transport kinetics of CPY for representative mutants from each complementation group that exhibited a conditional growth defect. The vacuolar hydrolase CPY is initially synthesized in the ER as a core-glycosylated p1 proenzyme, which is then converted to a p2 form in the Golgi complex by modification of core oligosaccharides and subsequently processed to the mature form (mCPY) upon arrival in the vacuole (STEVENS et al. 1982 Down). Wild-type and mutant cells were grown to mid-log phase at permissive temperature (30°), shifted to the nonpermissive temperature (15° or 37°) for 1 hr, pulse-labeled with [35S]methionine for 10 min, and chased for 60 min (15°) or 15 min (37°). Aliquots of cells were removed at different chase times and CPY was recovered by immunoprecipitation with anti-CPY antiserum. The half times of CPY transport from the ER to the vacuole were nearly 60 min at 15° (Figure 2B) and ~5 min at 37° (Figure 2C and estimated from other experiments not shown) in the wild-type cells. swa2-2, swa3-2, swa4-2, swa5-1, and swa7-1 mutants exhibited a defect in the kinetics of CPY transport and a subtle defect in Golgi-specific glycosylation at their nonpermissive temperatures (Figure 2B, and Figure 2C). In several pulse-chase experiments with these mutants, we noticed that p2 CPY could not be resolved from p1 CPY and that mCPY migrated slightly faster in the gels than mCPY from wild-type cells. Figure 2A shows a summary from at least two pulse-chase experiments of the CPY transport kinetics observed in the swa mutants at their nonpermissive temperatures, relative to wild-type and arf1{Delta} cells. The swa3-2, swa4-2, swa6-1, and swa7-1 mutants exhibited a defect in CPY transport comparable to that observed in arf1{Delta} cells (approximately threefold delay in transport, marked as ++). swa6-1 consistently incorporated significantly less [35S]methionine into TCA precipitable proteins than the other mutants and is not shown in Figure 2. The swa1-2 mutant was indistinguishable from wild type (++++), whereas swa2-2 mutants displayed a modest but reproducible transport defect (+++). The swa5-1 mutant displayed the strongest defect in CPY transport, with a three- to sixfold increase in the half time of CPY maturation (+). For swa3-2, swa4-2, and swa5-1, a slight CPY transport defect was apparent at 30° but was exaggerated at the nonpermissive temperature.

As described above, several of the swa mutants displayed cs growth and protein transport defects that are very similar to those observed in arf1{Delta} cells (STEARNS et al. 1990B Down). Moreover, we found that some mutants were also hypersensitive to fluoride, which is another phenotype exhibited by arf1{Delta} mutants (STEARNS et al. 1990B Down). The wild-type strains used in the study can grow on medium containing up to 80 mM NaF while the isogenic arf1{Delta} mutants can grow on 40 mM but not 60 mM NaF. Interestingly, swa3 mutants (swa3-1 and swa3-2) were extremely sensitive to fluoride and were not able to grow on the lowest concentration tested (20 mM). swa4-1, swa5-1, and swa7-1 mutants were as sensitive to fluoride as the arf1{Delta} mutants, whereas swa2-2 exhibited a sensitivity intermediate to swa3-2 and arf1{Delta} (Figure 2A). Again, the swa1-2 mutants behaved more like the wild-type strain (Figure 2A).

Mutations in SEC7, SEC21 ({gamma}-COP), GEA1 (ARF-guanine nucleotide exchange factor), and GCS1 (ARF-GTPase activating protein) were previously found to display genetic interactions with the arf1{Delta} mutation (STEARNS et al. 1990B Down; PEYROCHE et al. 1996 Down; POON et al. 1996 Down). To test for allelism to the SWA genes defined here, plasmids carrying GEA1, GCS1, and SEC7 were transformed into at least one representative mutant from each SWA complementation group. However, none of the transformants showed a sectoring phenotype, suggesting that these genes can neither suppress nor complement any of the swa mutants. In addition, all of the swa ts mutants were crossed with sec21 ts strains and the resultant diploids were all able to grow at 37°, suggesting that a sec21 mutant allele was not isolated in this screen.

The clathrin heavy chain (CHC1) gene complements the ts and protein transport defect of swa5-1 mutants:
Since the swa5-1 mutant exhibited a ts growth defect and markedly slow CPY transport kinetics, we decided to first focus on SWA5 characterization. The SWA5 gene was cloned by complementing the ts phenotype of the mutant. From a yeast low-copy genomic library, we isolated a plasmid carrying an ~10.8-kb insert from chromosome VII (pCC1-2) containing two open reading frames, CDC68 and CHC1 (Figure 3A). Deletion of a 1735-bp fragment in CHC1 ({Delta}NsiI) disrupted the ability of this plasmid to complement the growth defects of swa5-1 mutants at 37° while a fragment containing only full-length CHC1 complemented the ts phenotype (Figure 3, A and B). Even though ARF has been implicated in AP-1/clathrin recruitment to Golgi membranes, this was a surprising result because CPY transport has been characterized in chc1 mutants previously with no defect observed in a null mutant (PAYNE et al. 1988 Down) and only a transient missorting defect observed in a chc1 ts (chc1-521) strain shifted to the nonpermissive temperature (SEEGER and PAYNE 1992A Down). Therefore, we tested to determine if CPY is missorted and secreted from the swa5-1 mutant and if CHC1 can correct the CPY transport defects. Cells were converted to spheroplasts, and, after shifting to 37° for 1 hr, a pulse-chase experiment similar to that described above was performed with the swa5-1 mutant and the mutant carrying CHC1 on a plasmid. The swa5-1 mutant was again found to exhibit defects in CPY transport kinetics (approximately fivefold slower) and glycosylation of CPY, while wild-type CHC1 corrected both defects (Figure 3C). The stronger transport defect observed in this experiment was most likely the result of performing the pulse chase in spheroplasted cells. CPY was immunoprecipitated from both cells and medium in this experiment, but very little CPY was detected in the medium samples (Figure 3C), indicating that CPY was not being missorted. In addition, all of the CPY was converted to the mature form at longer chase times (data not shown), indicating that p2 CPY was not secreted from the cell. Shifting to 37° for 5 min prior to labeling swa5-1 mutants caused a less dramatic CPY transport defect and still no CPY was found in the medium (data not shown). Therefore, CPY is not missorted in the swa5-1 mutant, and CHC1 complemented both the ts growth and protein transport defects exhibited by swa5-1 mutants, suggesting that swa5-1 may be an allele of CHC1.

The swa5-1 mutation resides within CHC1:
To determine whether SWA5 is allelic to CHC1, gap rescue (ROTHSTEIN 1991 Down) was performed to recover segments of the CHC1 gene from the swa5-1 mutant. Plasmids gapped at four different regions within CHC1 (Figure 4) were transformed into a swa5-1 mutant to repair the missing portions using sequence information from the chromosomal CHC1 gene of the swa5-1 mutant. The repaired plasmids were subsequently rescued, amplified, and transformed back into the swa5-1 mutants to test for the ability to complement the ts phenotype. The rescued plasmid that was originally gapped at the very 3' end of CHC1 (Figure 4, Gap 1, {Delta}AatII-BamHI) did not complement the swa5-1 ts growth defect, indicating that a mutation(s) was located within this region. DNA sequencing revealed that a G at nucleotide position 4831 is missing, which results in a frameshift mutation 43 codons before the end of the open reading frame and consequently a truncated clathrin heavy chain (Chc1p) with 28 missense amino acids at the C terminus (see Figure 7A). Since these data indicated that the swa5-1 mutation resides in the CHC1 gene, we will now refer to the swa5-1 allele as chc1-5.

Immunoblotting was performed to examine the stability of the mutant Chc1p. Strains harboring chc1-5, chc1-521, or chc1-{Delta} alleles and wild-type strains were grown to mid-log phase at 23° and then shifted to 37°. Lysates from cells taken at the indicated time points were subjected to SDS-PAGE, blotted, and then probed with Chc1p and CPY antibodies, the latter to control for equal loading of the gel. As expected from the chc1-5 mapping and sequencing data, the mobility of the mutant protein was indistinguishable from that of the wild-type Chc1p. However, the level of Chc1-5 protein was reduced in cells growing at a permissive temperature and dropped substantially when the cells were shifted to 37° (Figure 5, lanes 4–6). Interestingly, the level of wild-type Chc1p also dropped after cells were shifted to 37° for 1 hr and increased somewhat by 2 hr (Figure 5, lanes 1–3). The loss of mutant Chc1p after temperature shift appeared more gradual for the chc1-521 mutant even compared to the isogenic wild-type strain (Figure 5, lanes 7–12).

The genetic interaction between arf1 and chc1 is not allele specific:
To test for a synthetic interaction of chc1-5 with arf1 mutations other than arf1{Delta}, two arf1 mutant alleles carried on plasmids (KAHN et al. 1995 Down) were used: [D26G] arf1 (pJCY1-58) carrying a point mutation in the GTP-binding domain, which encodes an Arf1p with a decreased affinity for GTP; and [W66R] arf1 (pJCY1-62), which is able to complement the fluoride sensitivity of arf1{Delta} mutants at 30° but not at 37°, suggesting that the encoded Arf1p is partially defective. Progeny of the cross between arf1{Delta} pJCY1-58 (or pJCY1-62) and chc1-5 mutants were characterized by random spore analyses. The [W66R] arf1 allele can efficiently rescue the synthetic lethality between chc1-5 and arf1{Delta}, because an equal number of arf1{Delta} chc1-5 and arf1{Delta} SWA5 segregants were recovered among the progeny that retained the plasmid. However, a modest growth defect was observed for the [W66R] arf1 chc1-5 double mutants at 30° that was not observed for the parental single mutant strains (data not shown). In contrast, no chc1-5 arf1{Delta} double mutants carrying [D26G] arf1 were recovered among 67 progeny tested, indicating that [D26G] arf1 cannot rescue the synthetic lethal interaction between arf1{Delta} and chc1-5. Therefore, the genetic interaction between arf1 and chc1-5 is not restricted to the arf1{Delta} allele, but is also observed for at least one point mutation in ARF1. In addition, crosses between strains harboring arf1{Delta} and other chc1 alleles (chc1-521 and chc1-{Delta}57) have been performed to construct double mutants. Although the frequency of viable double mutant progeny from these crosses appeared greater than for arf1{Delta} chc1-5, the viable arf1{Delta} chc1-521 and arf1{Delta} chc1-{Delta}57 strains also grew extremely poorly (data not shown).

The chc1-5 mutant mislocalizes Golgi enzymes to the plasma membrane:
Previous studies showed that clathrin function is required at late Golgi compartments for retaining resident Golgi enzymes, like Mnn1p, Kex2p, and dipeptidylaminopeptidase A, which are mislocalized to the plasma membrane of chc1 mutants (PAYNE and SCHEKMAN 1989 Down; SEEGER and PAYNE 1992B Down; GRAHAM et al. 1994 Down). The loss of Kex2p from the late Golgi compartment results in inefficient processing of pro-{alpha}-factor and secretion of this precursor form from chc1 mutants. We also found that the chc1-5 mutant (CCY620-5) secreted {alpha}-factor precursor at the nonpermissive temperature to the same extent as other chc1 mutants (data not shown). To directly determine if Golgi enzymes were mislocalized to the plasma membrane of the chc1-5 mutant incubated at the nonpermissive temperature, perhaps causing the glycosylation defects (Figure 3C), we analyzed the extent of mislocalization of the fusion protein M39I, containing the reporter enzyme invertase attached to the cytoplasmic tail and transmembrane domain (Golgi-localization signal) of Mnn1p. Wild-type and chc1-5 cells expressed 5–7% of M39I on the plasma membrane at the permissive temperature (Figure 6, 0 hr). In wild-type cells, the percentage of M39I in the plasma membrane did not change during a 2 hr incubation at 37°. In contrast, chc1-5 cells mislocalized ~2.5-fold more M39I to the plasma membrane after temperature shift (Figure 6). These phenotypes exhibited by the chc1-5 mutant, secretion of {alpha}-factor precursor and mislocalization of a Golgi-retained reporter protein to the plasma membrane, are similar to those previously described for other chc1 mutants.

The CPY transport defect exhibited by the chc1-5 mutant is allele-specific:
The chc1-5 mutant exhibited a kinetic defect in CPY transport that has not been observed in strains harboring other mutant alleles of chc1 (PAYNE et al. 1988 Down; LEMMON et al. 1991 Down; SEEGER and PAYNE 1992A Down). We suspected that differences in strain background might affect the phenotype of the chc1 ts mutants. For instance, deletion of CHC1 results in a lethal phenotype in some strain backgrounds, but causes slow-growing viable cells in others (PAYNE et al. 1987 Down; LEMMON et al. 1990 Down). To determine if the defect in CPY transport kinetics exhibited by the chc1-5 mutant is due to the strain background or is an allele-specific effect, we generated isogenic strains carrying chc1-5 and two other well-studied chc1 ts mutant alleles (chc1-521 and chc1-{Delta}57; LEMMON et al. 1991 Down; SEEGER and PAYNE 1992B Down; Figure 7A) in the SEY6210 strain background and compared the phenotypes. Integrating plasmids carrying only the 3' half of the chc1 mutant alleles (5'{Delta} chc1*) were constructed, linearized, and transformed into SEY6210 to simultaneously disrupt the wild-type CHC1 gene and integrate the mutant alleles (Figure 7B). All the resulting chc1 mutants were ts for growth. The isogenic strains were grown at 23°, shifted to 37° for 1 hr, and subjected to pulse-chase labeling to analyze CPY transport. Mutants harboring chc1-521 and chc1-{Delta}57 exhibited CPY transport kinetics similar to those of the wild-type strain, but the chc1-5 mutants still displayed the slow transport defect (Figure 7C). These results indicate that the chc1-5 mutant allele indeed causes the slow CPY transport and other chc1 ts alleles do not affect CPY transport in the SEY6210 background after 1 hr preincubation at 37°.

Although chc1-5 and chc1-{Delta}57 encode similar mutant forms of the clathrin heavy chain, the effects of these mutations on CPY transport were quite different. To determine if this phenotypic difference was caused by the addition of 28 missense amino acids or by the loss of the C-terminal 43 amino acids, we introduced a stop codon at position 1611 to produce the chc1-{Delta}43 allele (Figure 7A). The chc1-{Delta}43 mutation also causes a ts growth defect in the SEY6210 background, similar to the other isogenic chc1 mutants generated. As shown in Figure 7C, chc1-{Delta}43 mutant cells exhibited normal transport kinetics for CPY but did exhibit a partial defect in glycosylation, as p2 CPY was not resolved well from p1 CPY. Therefore, it appears that it is the 28 missense amino acids at the very C terminus of the Chc1-5 protein that interfere with transport, rather than the lack of the C-terminal 43 amino acids. Furthermore, the inefficient conversion of p1 to p2 CPY in the chc1-5 mutant gives the impression that transport from the ER to Golgi is the slow transport step. However, the chc1-{Delta}43 mutant exhibits a similar glycosylation defect but normal transport kinetics for CPY, suggesting that the apparent accumulation of p1 CPY in chc1-5 cells is caused by underglycosylation rather than a defect in ER-to-Golgi transport. This glycosylation defect is probably due to the mislocalization of {alpha}1,3 mannosyltransferase (Mnn1p), which is primarily responsible for the conversion of p1 to p2 CPY (GRAHAM et al. 1994 Down).

chc1-5 specifically perturbs the vacuolar protein transport route taken by CPY:
There are at least three known routes for transfer of newly synthesized proteins out of the Golgi complex: (1) secretion to the cell surface; (2) transport via endocytic compartments (or endosomes) to the vacuole, which is the route taken by CPY and is perturbed in vps mutants; and (3) the route taken by alkaline phosphatase (ALP) to the vacuole, which is not perturbed in most vps mutants (COWLES et al. 1997 Down; PIPER et al. 1997 Down). To better define the protein transport defect in chc1-5 cells, we tested whether proteins transported by the other two routes are affected as well. Pulse-chase experiments were performed to assess the transport kinetics of invertase and ALP. The former is a soluble protein that is rapidly secreted from cells and the latter is a vacuolar transmembrane protein that is apparently directly transported to the vacuole without passing through an endosomal compartment. The ALP pathway requires an adaptor-related AP-3 complex, which is thought to act independently of clathrin (COWLES et al. 1997 Down; PIPER et al. 1997 Down; PANEK et al. 1997 Down; STEPP et al. 1997 Down; VOWELS and PAYNE 1998 Down). In wild-type cells labeled at 37°, about half of the invertase was secreted by 5 min of chase and nearly all was in the medium at 15 min (Figure 8A). The kinetics of invertase secretion from chc1-5 cells was very similar, with ~90% secreted by 15 min. The invertase secreted from the chc1-5 mutant was clearly underglycosylated (Figure 8A), consistent with the underglycosylation of CPY and mislocalization of Golgi enzymes described above (Figure 3C and Figure 6). The kinetics of ALP transport was monitored by the time required for proteolytic processing of pro-ALP to mature (m) ALP. In wild-type cells, slightly more than half of the pro-ALP was processed at 5 min and nearly all was processed by 15 min (Figure 8B). Again, the kinetics of ALP transport in the chc1-5 cells was very similar, with half of pro-ALP processed to mALP at 5 min and most in the mature form at 15 min (Figure 8B). CPY immunoprecipitated from the same extracts showed an approximately fourfold increase in the half time for transport (data not shown). In addition, the transport kinetics of another vacuolar protein that follows the CPY route, carboxypeptidase S (CPS), also showed a three- to fourfold increase in the half time for vacuolar delivery (data not shown). These data suggest that protein transport through the secretory pathway is not significantly affected by the chc1-5 mutation, nor is transport of ALP from the Golgi to the vacuole. Therefore, the chc1-5 mutation specifically perturbs the transport route taken by CPY and CPS from the Golgi to the vacuole, supporting a role for CHC1 in this pathway.



View larger version (48K):
In this window
In a new window
Download PPT slide
 
Figure 8. Transport of invertase and alkaline phosphatase in the chc1-5 mutant. (A) Strains SEY6210 pCYI-20 (WT) and CCY620-5 pCYI-20 (chc1-5) were labeled and then chased as described in the legend to Figure 7C and converted to spheroplasts. Cells (C) and medium (M) were separated by centrifugation and subjected to immunoprecipitation with antiserum to invertase. (B) Isogenic strains SEY6210 (WT) and 6210 chc1-5 (chc1-5) were labeled and then chased as described in the legend to Figure 7C and subjected to immunoprecipitation with antiserum to ALP.


*  DISCUSSION
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

Identification of mutations that exhibit synthetic lethality with arf1{Delta}:
We have initiated a genetic screen to find factors that functionally interact with ARF and have defined seven complementation groups of swa mutants. Strains harboring the arf1{Delta} null allele exhibit phenotypes of cs growth, hypersensitivity to fluoride ions, an approximately threefold delay in the kinetics of protein transport through the secretory pathway, and Golgi-specific glycosylation defects (STEARNS et al. 1990A Down, STEARNS et al. 1990B Down; GAYNOR et al. 1998 Down). Importantly, most of the swa mutants exhibit very similar phenotypes suggesting that these mutations perturb cellular functions similar to those perturbed in the arf1{Delta} mutant. The basis of the screen, synthetic lethality between swa and arf1{Delta} mutations, also strongly implicates the SWA genes in ARF function in vivo. Of particular note, the swa3 cs mutants grow poorly at temperatures as high as 23° (data not shown) and are also extremely hypersensitive to fluoride ions (Figure 2A). The cold and fluoride sensitivity of the arf1{Delta} mutant could be explained by partial loss of SWA3 function if ARF is an upstream activator of Swa3p.

Genes previously found to display genetic interactions with ARF1, such as SEC21, SEC7, GEA1, and GCS1, were apparently not represented among the seven complementation groups defined here. This could be due to differences in the extent of the synthetic defect exhibited by distinct genetic strains. For instance, coatomer mutants were not found to be synthetically lethal with arf1{Delta} in the SEY6210 background (GAYNOR et al. 1998 Down), indicating that differences in the genetic background may influence the extent of the synthetic interaction. However, our screen was clearly not saturated and some of the original mutants that remain uncharacterized may carry mutant alleles of these genes. Because double arf1{Delta} arf2{Delta} mutants are inviable, ARF2 is a gene that should be identified in the screen. However, diploid strains of the genotype ade2/ade2 ade3/ade3 arf1{Delta}/arf1{Delta} ARF2/arf2{Delta} pADE3 ARF1 were not able to sector (data not shown), suggesting that a single copy of wild-type ARF2 is insufficient for a diploid cell to live. Therefore, strains carrying mutations in the ARF2 gene in this screen would appear as harboring dominant mutations. Since all of the swa mutations tested were recessive, it is unlikely that ARF2 is any of the SWA genes. This is difficult to test directly because transformation of the swa mutants with ARF2 carried on a CEN plasmid suppresses the nonsectoring phenotype of most of the mutants. The fact that a single copy of ARF2 rescues the synthetic lethality between arf1{Delta} and the swa mutations indicates that a specific threshold level of ARF is crucial for survival of the swa mutants.

Synthetic lethal interaction between arf1 and chc1:
The swa5-1 (chc1-5) mutant, which exhibits a ts growth phenotype and the most severe CPY transport defect of any swa mutant isolated, carries a mutation near the 3' end of the clathrin heavy chain (CHC1) gene. Here, we have shown that arf1{Delta} chc1-5 and [D26G]arf1 chc1-5 double mutants are inviable or exhibit an extreme growth defect not observed in the single mutants. The arf1{Delta} chc1-521 and arf1{Delta} chc1-{Delta}57 double mutants are viable but grew extremely poorly. Together, these findings of strong genetic interactions between arf1 and chc1 mutations provide in vivo support for a functional interaction between ARF and clathrin. Because in vitro studies have suggested that ARF is required for the binding of AP-1, and subsequently clathrin, to Golgi membranes (STAMNES and ROTHMAN 1993 Down; TRAUB et al. 1993 Down), perhaps the combination of a decreased concentration of ARF and clathrin heavy chain in the double mutants reduces the membrane-associated clathrin below a threshold required for our strains to survive. It is less likely that a requirement for ARF in the early secretory pathway combined with one for clathrin in the later secretory pathway causes synthetic lethality of the chc1 arf1{Delta} double mutant, because double mutants harboring ret1-1 ({alpha}-COP) and chc1 have been constructed and show only a modest synthetic growth defect (data not shown).

It is not known if ARF provides a binding site for coat assembly on a membrane or if ARF alters the membrane in a manner that allows efficient coat assembly. ARF is a potent activator of mammalian phospholipase D and it appears that the requirement for ARF in COPI vesicle formation can be replaced by pretreatment of Golgi membrane with phospholipase D (KTISTAKIS et al. 1996 Down). In this regard, it is significant that we have previously observed striking morphological changes in the structure of Golgi and endosomes in the arf1{Delta} mutant (GAYNOR et al. 1998 Down), which are distinct from the structures observed in clathrin or coatomer mutants. The arf1{Delta} mutant accumulates what appear to be large spheres of interconnected membrane tubules (GAYNOR et al. 1998 Down). It is possible that these structures result from an altered membrane composition and do not provide the appropriate surface for clathrin to assemble on or bud vesicles from. This may provide an alternative explanation for the observed synthetic lethality.

The role of clathrin in vacuolar protein transport:
In mammalian cells, the cytoplasmic domain of the mannose-6-phosphate receptors is recognized by clathrin/AP-1 at the trans-Golgi network and directly packaged into vesicles presumably targeted for prelysosomal (or endosomal) compartments (TRAUB and KORNFELD 1997 Down). In yeast, clathrin's role in the Golgi complex to sort vacuolar proteins from the secretory pathway is still controversial. Strains harboring a deletion of CHC1 do not show any protein transport or sorting defects (PAYNE et al. 1988 Down), suggesting that clathrin is not involved in vacuolar protein sorting. On the other hand, the finding that strains harboring chc1-521 transiently secrete precursors to soluble vacuolar proteins, such as CPY, upon shifting to the nonpermissive temperature provides the only evidence of a role for clathrin in sorting vacuolar proteins (SEEGER and PAYNE 1992A Down). After extended incubation at 37° chc1-521 cells correct the missorting defect and restore CPY sorting, presumably through a clathrin-independent pathway (SEEGER and PAYNE 1992A Down). Strains harboring the chc1-5 mutant allele isolated in this study exhibited a striking delay in CPY and CPS transport but only a slight effect on the transport kinetics of ALP and invertase. These data support a role for clathrin in the transport pathway that delivers CPY to the vacuole, which may be analogous to the route taken by mammalian lysosomal enzymes that bear mannose-6-phosphate. As previously suggested, it is possible that clathrin is essential for normal CPY transport but clathrin mutants adapt by diverting CPY into the ALP pathway (SEEGER and PAYNE 1992A Down), which requires the adaptor complex AP-3. Our data support the view that AP-3 functions independently of clathrin because ALP transport is unaffected in the chc1-5 mutant.

A clathrin triskelion consists of three heavy chains and three light chains, in which the heavy chain C termini associate to form a vertex with radially extended arms. A core trimerization domain has been mapped by limited proteolysis and expression of recombinant fragments to residues 1550–1587 with flanking sequences up to amino acid 1615 of the mammalian heavy chain required for formation of stable trimers (LIU et al. 1995 Down). The chc1-5 frameshift mutation lies within the region flanking the core trimerization domain (corresponding to amino acid 1605 of the mammalian heavy chain), which may cause triskelia to become unstable. In fact, a substantial reduction in the amount of Chc1p in the chc1-5 mutant was observed, particularly at 37° (Figure 5). It is likely that the remaining Chc1-5 protein can oligomerize because the chc1-5 mutant does not exhibit phenotypes suggesting a clathrin deficiency at a permissive temperature and a similar mutant heavy chain (Chc1-{Delta}57) has been shown to form trimers even at 37° (LEMMON et al. 1991 Down).

The kinetics of CPY transport to the vacuole is not affected in chc1 null, chc1-{Delta}57, or chc1-521 mutants (after 1 hr at 37°) but is significantly delayed in the chc1-5 mutant, which may imply that the Chc1-5 protein would have a dominant negative effect on protein transport. However, the CPY transport defect of chc1-5 mutants is clearly recessive (Figure 2C) and even overexpression of the chc1-5 allele in a wild-type strain does not affect CPY transport (data not shown). This suggests that hetero-trimeric clathrin coats consisting of wild-type and mutant heavy chains are functional but that the homo-trimeric Chc1-5 coat specifically interferes with CPY transport as the kinetics of ALP or invertase transport are relatively unaffected. The simplest explanation for these results is that the Chc1-5 protein can form coats on vesicles budding from the Golgi that contain CPY but the 28 missense amino acids at the C terminus partially interfere with the uncoating reaction, thereby interfering with the fusion of these vesicles with a prelysosomal compartment. Entrapment of ARF and clathrin on these vesicles could further reduce the available pool of these proteins in chc1-5 arf1{Delta} mutants and contribute to the synthetic lethal phenotype. Hsc70, an uncoating factor for clathrin, was found to bind near the vertex (C terminus) of isolated mammalian clathrin triskelia where it may be required to disrupt contacts between adjacent triskelia within a clathrin lattice (HEUSER and STEER 1989 Down). Perhaps this reaction is inefficient in strains harboring chc1-5 mutation.

An alternate explanation for the CPY transport defect in the chc1-5 mutant cannot be ruled out with the present evidence. Since late Golgi proteins are mislocalized to the plasma membrane of clathrin mutants, possibly including proteins of the transport machinery such as v-SNARES, the transport of CPY may be affected indirectly in the chc1-5 mutant. Although the Golgi protein mislocalization phenotype of chc1-5 cells appeared comparable to that of chc1-{Delta}57 or chc1-521 cells, the chc1-5 mutant exhibited a glycosylation defect not observed in the other mutants. This suggests that the chc1-5 mutation perturbs Golgi organization more substantially than the other chc1 mutants and it is possible that the CPY transport route is more sensitive to perturbation of the Golgi than is the ALP transport route. Additional work will be required to distinguish between these two models.


*  ACKNOWLEDGMENTS

We gratefully acknowledge Markus Aebi, Tim Stearns, Rick Kahn, Greg Payne, Sandra Lemmon, Bruce Horazdovsky, Catherine Jackson, Gerald Johnston, Alex Franzusoff, and Scott Emr for strains and plasmids and Sandra Lemmon for the Chc1p antibody. We also thank Jeff Flick and members in the Graham lab for comments on the manuscript and for helpful discussions. This work was supported by grants from the National Institutes of Health (GM-50409) and the National Science Foundation (MCB-9600835) to T.R.G. and a National Cancer Institute Center Grant (CA 68485).

Manuscript received March 5, 1998; Accepted for publication June 16, 1998.


*  LITERATURE CITED
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

BEDNAREK, S. Y., M. RAVAZZOLA, M. HOSOBUCHI, M. AMHERDT, and A. PERRELET et al., 1995  COPI- and COPII-coated vesicles bud directly from the endoplasmic reticulum in yeast. Cell 83:1183-1196[Medline].

BENDER, A. and J. R. PRINGLE, 1991  Use of a screen for synthetic lethal and multicopy suppressee mutants to identify two new genes involved in morphogenesis in Saccharomyces cerevisiae. Mol. Cell. Biol. 11:1295-1305[Abstract/Free Full Text].

BOMAN, A. L., T. C. TAYLOR, P. MELANCON, and K. L. WILSON, 1992  A role for ADP-ribosylation factor in nuclear vesicle dynamics. Nature 358:512-514[Medline].

COWLES, C. R., G. ODORIZZI, G. S. PAYNE, and S. D. EMR, 1997  The AP-3 adaptor complex is essential for cargo-selective transport to the yeast vacuole. Cell 91:109-118[Medline].

DELL'ANGELICA, E. C., J. KLUMPERMAN, W. STOORVOGEL, and J. S. BONIFACINO, 1998  Association of the AP-3 adaptor complex with clathrin. Science 280:431-434[Abstract/Free Full Text].

DONALDSON, J. G., D. FINAZZI, and R. D. KLAUSNER, 1992  Brefeldin A inhibits Golgi membrane-catalysed exchange of guanine nucleotide onto ARF protein. Nature 360:350-352[Medline].

GAYNOR, E. C. and S. D. EMR, 1997  COPI-independent anterograde transport: cargo-selective ER to Golgi protein transport in yeast COPI mutants. J. Cell Biol. 136:789-802[Abstract/Free Full Text].

GAYNOR, E. C., S. TE HEESEN, T. R. GRAHAM, M. AEBI, and S. D. EMR, 1994  Signal-mediated retrieval of a membrane protein from the Golgi to the ER in yeast. J. Cell Biol. 127:653-665[Abstract/Free Full Text].

GAYNOR, E. C., C.-Y. CHEN, S. D. EMR, and T. R. GRAHAM, 1998  ARF is required for maintenance of yeast Golgi and endosome structure and function. Mol. Biol. Cell 9:653-670[Abstract/Free Full Text].

GRAHAM, T. R. and V. A. KRASNOV, 1995  Sorting of yeast {alpha}-1,3-mannosyltransferase is mediated by a lumenal domain interaction, and a transmembrane domain signal that can confer clathrin-dependent Golgi localization to a secreted protein. Mol. Biol. Cell 6:809-824[Abstract].

GRAHAM, T. R., M. SEEGER, G. S. PAYNE, V. MACKAY, and S. D. EMR, 1994  Clathrin-dependent localization of {alpha}1,3 mannosyltransferase to the Golgi complex of Saccharomyces cerevisiae. J. Cell Biol. 127:667-678[Abstract/Free Full Text].

HELMS, J. B. and J. E. ROTHMAN, 1992  Inhibition by brefeldin A of a Golgi membrane enzyme that catalyzes exchange of guanine nucleotide bound to ARF. Nature 360:352-354[Medline].

HEUSER, J. and C. J. STEER, 1989  Trimeric binding of the 70-kD uncoating ATPase to the vertices of clathrin triskelia: a candidate intermediate in the vesicle uncoating reaction. J. Cell Biol. 109:1457-1466[Abstract/Free Full Text].

HORAZDOVSKY, B. F., G. R. BUSCH, and S. D. EMR, 1994  VPS21 encodes a rab5-like GTP binding protein that is required for the sorting of yeast vacuolar proteins. EMBO J. 13:1297-1309[Medline].

JOHNSON, L. M., V. A. BANKAITIS, and S. D. EMR, 1987  Distinct sequence determinants direct intracellular sorting and modification of a yeast vacuolar protein. Cell 48:875-885[Medline].

KAHN, R. A., J. CLARK